Serum BDNF levels before treatment predict SSRI response in depression
about
BDNF DNA methylation changes as a biomarker of psychiatric disorders: literature review and open access database analysisA Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesInvolvement of genetic and environmental factors in the onset of depressionThe potential utility of pharmacogenetic testing in psychiatryEffects of negative stressors on DNA methylation in the brain: implications for mood and anxiety disordersAlterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.The Role of the Val66Met Polymorphism of the Brain Derived Neurotrophic Factor Gene in Coping Strategies Relevant to Depressive SymptomsEpigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants.Possible Involvement of µ Opioid Receptor in the Antidepressant-Like Effect of Shuyu Formula in Restraint Stress-Induced Depression-Like Rats.Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis.Blood BDNF level is gender specific in severe depressionExpression of monoamine transporters, nitric oxide synthase 3, and neurotrophin genes in antidepressant-stimulated astrocytesRadix Bupleuri ameliorates depression by increasing nerve growth factor and brain-derived neurotrophic factor.Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.Epigenetic Modulation of Mood Disorders.The Antidepressant Effect of Angelica sinensis Extracts on Chronic Unpredictable Mild Stress-Induced Depression Is Mediated via the Upregulation of the BDNF Signaling Pathway in RatsTLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation.Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs.Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosisBDNF in sleep, insomnia, and sleep deprivation.Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor.Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target.Loneliness in Relation to Depression: The Moderating Influence of a Polymorphism of the Brain Derived Neurotrophic Factor Gene on Self-efficacy and Coping Strategies.Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trialThe BDNF Val66Met polymorphism regulates glucocorticoid-induced corticohippocampal remodeling and behavioral despairDifferential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice.The role of 5-hydroxytryptamine receptor subtypes in the regulation of brain-derived neurotrophic factor gene expression.Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.Relationship Between Brain-Derived Neurotrofic Factor (Bdnf) and Sleep on Depression: A Critical Review.Effect of Agomelatine and Fluoxetine on HAM-D Score, Serum Brain-Derived Neurotrophic Factor, and Tumor Necrosis Factor-α Level in Patients With Major Depressive Disorder With Severe Depression.Antidepressant, antioxidant and neurotrophic properties of the standardized extract of Cocos nucifera husk fiber in mice.Additive clinical value of serum brain-derived neurotrophic factor for prediction of chronic heart failure outcome.Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression.The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response Study: Design and Methodology.
P2860
Q26748627-A4481806-065A-4383-B010-2B1AD60E6065Q26786354-7AA21DFC-9253-4638-BB49-4A63F6C35C71Q27027796-49868B9E-7607-4E66-83AB-3EB73AE684F4Q28084874-BA580857-39EF-4DBB-A344-3856370CCD45Q28822036-4F608259-D8C5-4F6E-AF54-E349944EF4E1Q30372214-266BFA27-FB37-45EB-A12E-A3350A576D43Q33718185-058A9FD0-7DE9-4FCF-B0AD-67033E8A62C9Q33842993-17B7AC4C-C9C0-43F6-9B1F-F922B0908419Q34793447-FF06D5D2-166D-440B-B5F6-44FA2293EA7CQ34864481-FF28E6FC-AE86-4A47-9829-3C5232A6FFB5Q35188355-64D81EE3-C28C-48F4-A0D5-2D9AC5767D30Q35233681-09C2E53B-96E4-4544-8F46-99A664CD6EB5Q35641038-35B9DB27-F44B-44B2-9A4A-75D025228AEFQ35899423-C38BC7B2-77AF-4C90-951A-55D5FAA04695Q35959514-3F4D8F07-6311-469A-873D-8CED541ECE5DQ36291647-7F2AE10B-0FD4-4B8D-8505-1D7B7CA4AF47Q36737217-644FA260-2110-4C2B-9DBC-50083CB2330DQ37239649-959B960A-6F59-4C3A-AB6B-36E22B368D20Q37349893-30057F55-CE15-48F9-B65F-C0BFB091E2C3Q37617306-EA95569C-D48C-48EE-99F9-DE8772D9D9D9Q38216015-8E934549-411A-4C58-9805-B34C00F75A5BQ38693724-08C9B5C1-8626-4417-9DBA-6CAB2C841015Q38742940-DE33902E-E3A1-4636-BD8A-55F650D6062DQ38831859-1FF805E1-BA25-4548-BCD8-C0370C0CD945Q41050624-57DFC398-A200-4918-9506-462A551D0096Q41502047-45F5CB7E-FB85-4D73-8445-EDF16FF36A7FQ42257136-BAE00790-9CD6-4518-BF95-F94F8E5F247AQ42671677-76CA61B8-7D47-40D8-B63D-FCBED8306C99Q45912223-8B443743-5E90-4BB0-B798-49F002CF7A91Q46588846-8D2E545D-F6E3-4B33-9729-110F74366E4EQ47649144-4DEE1AC1-20A2-4AE7-8BFD-267A5AF7092BQ47790524-A7BE76E4-73EB-4E3A-B408-C2DA006B006EQ48064443-A517B3ED-1FD2-4020-B26A-0966923B6BEAQ48129465-EF5A87E9-A778-4889-BAFA-B2260A2A646DQ48413276-970F9DC9-4035-4CE2-BD5A-5A6CD06ECB7BQ52662001-FB9D69C2-1389-413F-8DA7-356310629989Q55113792-B8079BD7-CE27-4870-9E89-4E5173D3DBF8
P2860
Serum BDNF levels before treatment predict SSRI response in depression
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Serum BDNF levels before treatment predict SSRI response in depression
@ast
Serum BDNF levels before treatment predict SSRI response in depression
@en
type
label
Serum BDNF levels before treatment predict SSRI response in depression
@ast
Serum BDNF levels before treatment predict SSRI response in depression
@en
prefLabel
Serum BDNF levels before treatment predict SSRI response in depression
@ast
Serum BDNF levels before treatment predict SSRI response in depression
@en
P2093
P2860
P50
P1476
Serum BDNF levels before treatment predict SSRI response in depression
@en
P2093
George K Lerner
Heather M Burke
J Craig Nelson
Jessica Wolf
Rebecca Rosser
Synthia H Mellon
Wendy Shelly
P2860
P304
P356
10.1016/J.PNPBP.2011.06.013
P577
2011-07-03T00:00:00Z